Testing a new treatment for mild-to-moderate ulcerative colitis
Part of Digestive system clinical trials.
This study tests an investigational drug for people with active mild-to-moderate ulcerative colitis. It aims to see if the drug can improve symptoms without needing advanced treatments like biologics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ulcerative colitis for at least 3 months.
- Your colitis is active but mild to moderate, affecting at least 10 cm of your colon.
- You are currently taking or have tried a 5-ASA medication (like mesalamine) and it didn't work well enough or you couldn't tolerate it.
- You have not used any advanced UC treatments (such as infliximab, vedolizumab, or tofacitinib) before.
- You are willing to use effective contraception if you could become pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new combination of two drugs to see if they are safe and help reduce ulcerative colitis symptoms. It is for people who have not gotten enough relief from other treatments.
This study tests several new treatments to see if they are safe and helpful for people with moderate to severe ulcerative colitis. If you have not responded well to standard treatments, this might be an option.
This Phase 1 trial tests a new drug called LMT503 in adults to learn its safety, tolerability, and how the body handles it. If you qualify, you may receive the study medicine in a controlled research setting with regular checkups and blood/heart monitoring.
This trial tests an investigational drug called MK-8690 for people with moderate to severe ulcerative colitis (UC) who haven't responded well to other treatments or can't tolerate them. The study aims to see if the drug can help control UC symptoms safely.
This study tests an investigational drug called MB-001 for people with moderate to severe ulcerative colitis who have already tried standard treatments without success. It aims to see if the drug is safe and helps control inflammation.
This study tests an experimental tablet for people with moderate to severe ulcerative colitis that hasn't improved with standard treatments. It aims to see if the tablet can reduce symptoms and inflammation.
Hear when a new Colitis, Ulcerative trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.